|
Comparison of primary tumor gene methylation status relative to ER status |
|||||
| Gene |
ER negative (n = 65) |
ER positive (n = 65) |
P valuea |
||
|
|
|||||
| n |
% |
n |
% |
||
|
|
|||||
| RASSF1A |
36 |
55% |
60 |
92% |
<0.0001 |
| CCND2 |
26 |
40% |
45 |
69% |
0.0008 |
| GSTP1 |
4 |
6% |
19 |
29% |
0.0006 |
| TWIST |
17 |
26% |
32 |
49% |
0.0066 |
| APC |
20 |
31% |
31 |
48% |
0.048 |
| NES1 |
13 |
20% |
22 |
34% |
NS |
| RARβ2 |
18 |
28% |
17 |
26% |
NS |
| CDH1 |
53 |
82% |
54 |
83% |
NS |
|
aχ2 test or Fisher's exact test was used appropriately. ER, estrogen receptor; NS, not significant. | |||||
Sunami et al. Breast Cancer Research 2008 10:R46 doi:10.1186/bcr2098 |
|||||